SCHEMBL29720133

SCHEMBL29720133

Cc1ncc(C(=O)NC23CC(C2)C3)c(N2CC[C@](C)(N)C2)c1-c1cc(F)cc(F)c1

nearest known ligand 0.37

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ PTPN11 Q06124 6/20 0.37
▸ PIK3C3 Q8NEB9 2/20 0.34
▸ CNR2 P34972 5/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ USP30 Q70CQ3 1/20 0.33
▸ RPS6KB1 P23443 3/20 0.32
▸ NTRK1 P04629 2/20 0.32
▸ JAK2 O60674 1/20 0.32
▸ NPY5R Q15761 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22976472 1.00 PTPN11 (0.37) PTPN11PIK3C3CNR2CNR1USP30
SCHEMBL22976203 1.00 PTPN11 (0.37) PTPN11PIK3C3CNR2CNR1USP30
SCHEMBL22976580 0.91 PTPN11 (0.39) PTPN11PIK3C3CNR2CNR1
SCHEMBL22976579 0.91 PTPN11 (0.39) PTPN11PIK3C3CNR2CNR1
SCHEMBL29720115 0.91 PTPN11 (0.39) PTPN11PIK3C3CNR2CNR1
SCHEMBL22976551 0.89 PTPN11 (0.35) PTPN11PIK3C3CNR2CNR1RPS6KB1
SCHEMBL22976861 0.89 USP30 (0.34) PIK3C3CNR2CNR1USP30NTRK1
SCHEMBL22976860 0.89 USP30 (0.34) PIK3C3CNR2CNR1USP30NTRK1
SCHEMBL22976156 0.88 PTPN11 (0.35) PTPN11PIK3C3CNR2CNR1USP30
Hydrochloric Acid SCHEMBL28777538 0.88 PTPN11 (0.35) PTPN11PIK3C3CNR2CNR1RPS6KB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119504705-A Non-peptide somatostatin 5 receptor agonists and uses thereof 克林提克斯医药股份有限公司 2025-02-25 — — CN disclosed
CN-114585614-B Non-peptide somatostatin 5 receptor agonists and uses thereof 克林提克斯医药股份有限公司 2024-12-03 — — CN disclosed
EP-4013748-A1 NONPEPTIDE SOMATOSTATIN TYPE 5 RECEPTOR AGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. (US) 2022-06-22 — — EP disclosed
Send feedback